Showing results (731-740 of 1,006) with videos related to
Sort By:
Pageof 101
Biochemical and Biophysical Research Communications|May 1, 2012
Biphasic effect of danazol on human vascular endothelial cell permeability and f-actin cytoskeleton dynamicsGregory W Thomas, Leonard T Rael, Raphael Bar-Or, et al.Anti-Cancer Drug Design|June 1, 1995
Antineoplastic agents 322. synthesis of combretastatin A-4 prodrugsG R Pettit, C Temple, V L Narayanan, et al.Veterinary Pathology|May 1, 1983
Paralysis in swine due to focal symmetrical poliomalacia: possible selenium toxicosisL H Harrison, B M Colvin, B P Stuart, et al.Transplantation|August 1, 1991
Anti-CD3 monoclonal antibody therapy. An approach toward optimization by in vitro analysis of new anti-CD3 antibodiesE S Woodle, J R Thistlethwaite, L K Jolliffe, et al.Journal of Vascular Surgery|February 26, 2008
The effect of vein repair on the risk of venous thromboembolic events: a review of more than 100 traumatic military venous injuriesReagan W Quan, David L Gillespie, Rory P Stuart, et al.Connective Tissue Research|May 11, 2018
Regulation of osteogenesis by long noncoding RNAs: An epigenetic mechanism contributing to bone formationCoralee E Tye, Joseph R Boyd, Natalie A Page, et al.Frontiers in Bioengineering and Biotechnology|March 1, 2021
Toluene Dioxygenase-Catalyzed cis-Dihydroxylation of Quinolines: A Molecular Docking Study and Chemoenzymatic Synthesis of Quinoline Arene OxidesDerek R Boyd, Narain D Sharma, Pui L Loke, et al.Cancer Detection and Prevention. Supplement : Official Publication of the International Society for Preventive Oncology, Inc|January 1, 1987
Metastasis models for human tumors in athymic mice: useful models for drug developmentD L Fine, R Shoemaker, A Gazdar, et al.Molecular Pharmacology|October 20, 2000
Analysis of the interaction between the HIV-inactivating protein cyanovirin-N and soluble forms of the envelope glycoproteins gp120 and gp41B R O'Keefe, S R Shenoy, D Xie, et al.Antimicrobial Agents and Chemotherapy|February 1, 1995
Michellamine B, a novel plant alkaloid, inhibits human immunodeficiency virus-induced cell killing by at least two distinct mechanismsJ B McMahon, M J Currens, R J Gulakowski, et al.Pageof 101